SCHEMBL7194149

SCHEMBL7194149

CCc1ccc(OC(CC)CC)c(CCC(=O)c2ccccc2OC(CC)CC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.47
PPARD Q03181 8/20 0.47
PPARA Q07869 6/20 0.47
ABCB1 P08183 10/20 0.41
TSHR P16473 2/20 0.40
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
KCNK3 O14649 1/20 0.39
SLC22A1 O15245 1/20 0.39
ABCC9 O60706 1/20 0.39
KCNK2 O95069 1/20 0.39
ABCB11 O95342 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
ADRA2C P18825 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7190305 0.94 PPARG (0.48) PPARGPPARDPPARAABCB1TSHR
SCHEMBL7193925 0.90 PPARG (0.41) PPARGPPARDPPARAABCB1TSHR
SCHEMBL7196664 0.89 PPARG (0.46) PPARGPPARDPPARAABCB1TSHR
SCHEMBL7191811 0.86 PPARG (0.43) PPARGPPARDPPARA
SCHEMBL7187143 0.86 PPARG (0.48) PPARGPPARDPPARAABCB1TSHR
SCHEMBL7193320 0.85 PPARG (0.42) PPARGPPARDPPARAABCB1TSHR
SCHEMBL7196678 0.84 PPARG (0.47) PPARGPPARDPPARAABCB1TSHR
SCHEMBL7193844 0.84 NPC1 (0.51) ABCB1NPC1PKMRAB9A
SCHEMBL7193908 0.83 PPARG (0.40) PPARGPPARDPPARANPC1PKM
SCHEMBL7192760 0.83 PPARG (0.48) PPARGPPARDPPARAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 PPARG 659/4885PPARD 405/4885PPARA 600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.